載入...
Treatment Outcomes of Novel Targeted Agents in Relapse/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Network Meta-Analysis
Most chronic lymphocytic leukemia patients experience a relapse or become refractory to treatment with conventional chemotherapeutic agents. The network meta-analysis assesses the relative efficacy of novel targeted agents for the treatment of a relapse or refractory chronic lymphocytic leukemia. A...
Na minha lista:
| 發表在: | J Clin Med |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6572611/ https://ncbi.nlm.nih.gov/pubmed/31126075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8050737 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|